Thyroid Research Unit, Department of Medicine, The Icahn School of Medicine at Mount Sinai, The James J. Peters VA Medical Center, New York, New York, USA.
Thyroid. 2020 Nov;30(11):1666-1675. doi: 10.1089/thy.2019.0772. Epub 2020 May 27.
It has been demonstrated that the transcription factors TAZ (transcriptional coactivator with PDZ-binding motif), paired box gene 8 (PAX8), and NK2 homeobox 1 (NKX2-1) are coexpressed in the nucleus of thyroid cells. Furthermore, TAZ is known to enhance the transcriptional activity of PAX8 and NKX2-1 as well as the key thyroid-specific gene, thyroglobulin (TG), suggesting a critical role for TAZ in the control of thyroid cell speciation. We previously reported that the small molecule ethacridine, identified as a TAZ activator, was able to induce thyroid-specific transcription in endodermal cells differentiated from human embryonic stem (hES) cells using activin A. Since transcription factors are epigenetically regulated in cell differentiation, we investigated the epigenetic changes in the promoter regions of these key transcription factors during differentiation of hES cells into thyrocytes. We initially profiled chromatin accessibility using the technique of Assay for Transposase Accessible Chromatin sequencing (ATAC-seq), and then examined DNA methylation and histone acetylation in the promoter regions of the three selected thyroid transcription factors and the thyroid-specific genes during hES cell differentiation. ATAC-seq analysis showed enriched chromatin accessibility of TAZ, NKX2-1, and PAX8 after exposure to activin A and ethacridine. There were no methylation changes found in the NKX2-1, PAX8, and TAZ promoters by bisulfite sequencing. In contrast, acetylation of histone H4, specifically acetylation of lysine 16, was observed in each of the promoters when measured by chromatin immunoprecipitation polymerase chain reaction assays, which correlated with the activity and expression of NKX2-1 and PAX8 as well as sodium/iodide symporter, thyroid stimulating hormone receptor, and TG genes. These results indicate that ethacridine treatment of activin A-derived endodermal hES cells leads to enhanced chromatin accessibility, which, in turn, allows histone H4 acetylation in the regulation of active genes for speciation of thyroid follicular cells from hES cells.
已有研究表明,转录因子 TAZ(含 PDZ 结合基序的转录共激活因子)、配对盒基因 8(PAX8)和 NK2 同源盒 1(NKX2-1)在甲状腺细胞的核内共同表达。此外,TAZ 已知可增强 PAX8 和 NKX2-1 以及关键的甲状腺特异性基因——甲状腺球蛋白(TG)的转录活性,提示 TAZ 在控制甲状腺细胞特化中起着关键作用。我们之前曾报道,小分子吖啶橙被鉴定为 TAZ 激活剂,能够在使用激活素 A 将人胚胎干细胞(hES)分化为内胚层细胞后诱导甲状腺特异性转录。由于转录因子在细胞分化过程中受到表观遗传调控,我们研究了 hES 细胞向甲状腺细胞分化过程中这些关键转录因子启动子区域的表观遗传变化。我们最初使用转座酶可及染色质测序(ATAC-seq)技术对染色质可及性进行了分析,然后在 hES 细胞分化过程中检测了这三个选定的甲状腺转录因子和甲状腺特异性基因启动子区域的 DNA 甲基化和组蛋白乙酰化。ATAC-seq 分析显示,在暴露于激活素 A 和吖啶橙后,TAZ、NKX2-1 和 PAX8 的染色质可及性增加。通过亚硫酸氢盐测序未发现 NKX2-1、PAX8 和 TAZ 启动子的甲基化变化。相反,通过染色质免疫沉淀聚合酶链反应检测到每个启动子中组蛋白 H4 的乙酰化,特别是赖氨酸 16 的乙酰化,这与 NKX2-1 和 PAX8 以及钠/碘转运体、促甲状腺激素受体和 TG 基因的活性和表达相关。这些结果表明,吖啶橙处理激活素 A 衍生的内胚层 hES 细胞可导致染色质可及性增强,进而允许组蛋白 H4 乙酰化,从而调节 hES 细胞向甲状腺滤泡细胞特化的活性基因。